Risk of recurrence after neoadjuvant chemotherapy and transoral robotic surgery in patients with oropharynx cancer that avoid adjuvant radiation

Risk of recurrence after neoadjuvant chemotherapy and transoral robotic surgery in patients with oropharynx cancer that avoid adjuvant radiation

Abstract Background De‐escalation strategies for newly‐diagnosed p16‐positive oropharyngeal squamous cell carcinoma (p16+ OPSCC), aim to reduce treatment‐related morbidity without compromising disease control. One strategy is neoadjuvant cisplatin and docetaxel chemotherapy (NAC + S) before transora...

Full description

Bibliographic Details
Main Authors: Alisha R. Pershad, Punam G. Thakkar, Joseph F. Goodman, Arjun Joshi, Seth M. Steinberg, Clint T. Allen, Charalampos S. Floudas
Format: Article
Language:English
Published: Wiley 2024-04-01
Series:Cancer Medicine
Subjects:
adjuvant radiotherapy
de‐escalation
neoadjuvant chemotherapy
oropharynx cancer
transoral surgery
Online Access:https://doi.org/10.1002/cam4.7146

Internet

https://doi.org/10.1002/cam4.7146

Similar Items